Krystal Biotech Overview

  • Founded
  • 2017
Founded
  • Status
  • Public
  • Employees
  • 75
Employees
  • Stock Symbol
  • KRYS
Stock Symbol
  • Share Price
  • $77.00
  • (As of Monday Closing)

Krystal Biotech General Information

Description

Krystal Biotech Inc is engaged in the healthcare sector in the United States. It is a gene therapy company dedicated to developing and commercialising novel treatments for patients suffering from dermatological diseases. The company used its proprietary gene therapy platform, STAR-D to develop treatments for rare or orphan dermatological indications caused by the absence of or a mutation in a single gene. It plans to leverage its platform to expand its pipeline to include other dermatological indications in the future.

Contact Information

Ownership Status
Publicly Held
Financing Status
Corporate Backed or Acquired
Primary Industry
Biotechnology
Other Industries
Pharmaceuticals
Stock Exchange
NAS
Primary Office
  • 2100 Wharton Street
  • Suite 701
  • Pittsburgh, PA 15203
  • United States
+1 (412) 000-0000

Krystal Biotech Timeline

2018201920202021
Date FoundedFinancing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Krystal Biotech Stock Performance

(As of Monday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$77.00 $79.44 $37.68 - $87.29 $1.71B 22.2M 146K -$1.71

Krystal Biotech Financials Summary

In Thousands,
USD
TTM 31-Dec-2020 FY 2020 31-Dec-2020 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018
EV 899,189 899,189 758,653 247,539
Revenue 0 0 0 0
EBITDA (31,148) (31,148) (20,991) (11,775)
Net Income (32,167) (32,167) (19,088) (10,889)
Total Assets 310,844 310,844 209,023 116,116
Total Debt 11,546 11,546 3,262 0
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Krystal Biotech Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Krystal Biotech‘s full profile, request access.

Request a free trial

Krystal Biotech Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Krystal Biotech Inc is engaged in the healthcare sector in the United States. It is a gene therapy company dedicated to
Biotechnology
Pittsburgh, PA
75 As of 2020
00000
00000000 00000

000000 0

ectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim
000000000000000
Zug, Switzerland
000 As of 0000
00000
00000000000 00000

00000000

tur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad m
0000 000000000
Stevenage, United Kingdom
000 As of 0000
00000
0000 0000-00-00
00000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Krystal Biotech Competitors (57)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
CRISPR Therapeutics Formerly VC-backed Zug, Switzerland 000 00000 00000000000 00000
000000000 Venture Capital-Backed Stevenage, United Kingdom 000 00000 00000000 00000
0000 0000000000000 Venture Capital-Backed South San Francisco, CA 00 0000 0000000000 0000
0000000 Formerly VC-backed Cambridge, MA 000 00000 000000 - 000 00000
0000000 Formerly VC-backed Cambridge, MA 00 00000 00000000 00000
You’re viewing 5 of 57 competitors. Get the full list »

Krystal Biotech Executive Team (6)

Name Title Board Seat Contact Info
Krish Krishnan Chief Executive Officer, President, Director, Executive and Board Member
Suma Krishnan Chief Operating Officer, Operations & Board Member
Dino Rossi Board Member, Director, Member of the Audit Committee, Compensation Committee, Nominating, Corporate
Daniel Janney Chairman of the Compensation Committee, Member of the Audit Committee, Board Member & Director
Andy Orth Chief Commercial Officer
You’re viewing 5 of 6 executive team members. Get the full list »

Krystal Biotech Board Members (6)

Name Representing Role Since
000000 000000 Krystal Biotech Chairman of the Compensation Committee, Member of the Audit Committee, Board Member & Director 000 0000
0000 00000 Krystal Biotech Board Member, Director, Member of the Audit Committee, Compensation Committee, Nominating, Corporate 000 0000
000000 00000000 Self Board Member 000 0000
00000 00000000 Krystal Biotech Chief Executive Officer, President, Director, Executive and Board Member 000 0000
0. 00000 Krystal Biotech Board Member, Chairman of the Audit Committee, Member of the Compensation Committee and the Nominating and Corporate Governance Committee 000 0000
You’re viewing 5 of 6 board members. Get the full list »

Krystal Biotech Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial